^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in sterile water for injection.

^e Tested in dextrose 5%, Ringer’s injection, lactated, sodium chloride 0.45%, and sodium chloride 0.9%.

^f Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^g Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^h Tested as the premixed infusion solution.

ⁱ Tested with albumin human 0.1%.

^j Lyophilized formulation tested.

^k Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^l Injected into a line being used to infuse dopamine hydrochloride in dextrose 5% in sodium chloride 0.3% with potassium chloride 20 mEq.

^m Tested in dextrose 5% in sodium chloride 0.45%.

ⁿ Tested in Ringer’s injection, lactated.

^o Final concentration after mixing.

^p Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^q Test performed using the formulation WITHOUT edetate disodium.

^r Test performed using the formulation WITH edetate disodium.

^s Tested in either dextrose 5% or in sodium chloride 0.9%, but the report did not specify which solution.

^t Tested in a 1:1 mixture of (1) dextrose 5% and dextrose 5% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L and also in (2) dextrose 10% in sodium chloride 0.45% with and without potassium chloride 20 mEq/L.

^v Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^w Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^x Quinupristin and dalfopristin components combined.

^y Salt not specified.

^z Test performed using the Cubicin formulation.

^aa Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^bb Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^cc Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^dd Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^ee Tested with lidocaine HCl (AB) 8 mg/mL.

^ff Tested with nitroglycerin (LY) 0.4 mg/mL.

^gg Tested with sodium nitroprusside (ES) 0.4 mg/mL.

^hh Tested with dobutamine HCl (LI) 4 mg/mL.